Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

Clinical trial NCT06630416 · RECRUITING

Trial details

NCT number: NCT06630416
Sponsor: Northwestern University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Bladder Urothelial Carcinoma Metastatic Malignant Solid Neoplasm Stage IV Bladder Cancer AJCC v8 MTAP Deletion

Start date: 2024-11-27
Primary completion: 2029-05-10
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.